Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuyuki Miyata

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Infection|February 19, 2022
High titer of antibody against the SARS-CoV-2 spike protein among patients receiving neutralizing antibody cocktail therapy with REGN-COVHiroaki Sasaki, Nobuyuki Miyata, Yukihiro Yoshimura, et al.
Japanese Journal of Infectious Diseases|May 1, 2022
Intradermal Hepatitis B Vaccination in Non-responder People Living with Human Immunodeficiency Virus in JapanYukihiro Yoshimura, Hiroaki Sasaki, Nobuyuki Miyata, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 20, 2021
Antibody response after COVID-19 vaccine BNT162b2 on health care workers in JapanYukihiro Yoshimura, Hiroaki Sasaki, Nobuyuki Miyata, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 23, 2020
Clinical characteristics of the coronavirus disease 2019 (COVID-19) outbreak on a cruise shipYukihiro Yoshimura, Hiroaki Sasaki, Hiroshi Horiuchi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 13, 2019
Desensitization to trimethoprim-sulfamethoxazole in a toxoplasmic encephalitis patient who was intolerant to conventional treatmentsNobuyuki Miyata, Yukihiro Yoshimura, Kenji Hikosaka, et al.
Clinical Journal of Gastroenterology|November 27, 2018
Methimazole-induced acute pancreatitis: a case reportItsuka Kikuchi, Nobuyuki Miyata, Yukihiro Yoshimura, et al.
Clinical Journal of Gastroenterology|February 10, 2020
Hepatitis A virus infection in an HIV-positive man with previously confirmed immunity against hepatitis A virusYukihiro Yoshimura, Hiroshi Horiuchi, Nobuyuki Miyata, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 10, 2021
Recovery from severe persistent COVID-19 without evidence of an anti-SARS-CoV-2 antibody response in a man with mantle cell lymphoma treated with rituximabHiroshi Horiuchi, Hiroaki Sasaki, Kazuhito Miyazaki, et al.
The American Journal of Tropical Medicine and Hygiene|August 26, 2015
Cavity Forming Pneumonia Due to Staphylococcus aureus Following Dengue FeverNobuyuki Miyata, Yukihiro Yoshimura, Natsuo Tachikawa, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 27, 2016
Diseases affecting patients returning from abroad: Experience of a travel clinic in Japan from 2004 to 2014Yukihiro Yoshimura, Nobuyuki Miyata, Makiko Miyajima, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Infection|February 19, 2022
High titer of antibody against the SARS-CoV-2 spike protein among patients receiving neutralizing antibody cocktail therapy with REGN-COVHiroaki Sasaki, Nobuyuki Miyata, Yukihiro Yoshimura, et al.
Japanese Journal of Infectious Diseases|May 1, 2022
Intradermal Hepatitis B Vaccination in Non-responder People Living with Human Immunodeficiency Virus in JapanYukihiro Yoshimura, Hiroaki Sasaki, Nobuyuki Miyata, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 20, 2021
Antibody response after COVID-19 vaccine BNT162b2 on health care workers in JapanYukihiro Yoshimura, Hiroaki Sasaki, Nobuyuki Miyata, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 23, 2020
Clinical characteristics of the coronavirus disease 2019 (COVID-19) outbreak on a cruise shipYukihiro Yoshimura, Hiroaki Sasaki, Hiroshi Horiuchi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 13, 2019
Desensitization to trimethoprim-sulfamethoxazole in a toxoplasmic encephalitis patient who was intolerant to conventional treatmentsNobuyuki Miyata, Yukihiro Yoshimura, Kenji Hikosaka, et al.
Clinical Journal of Gastroenterology|November 27, 2018
Methimazole-induced acute pancreatitis: a case reportItsuka Kikuchi, Nobuyuki Miyata, Yukihiro Yoshimura, et al.
Clinical Journal of Gastroenterology|February 10, 2020
Hepatitis A virus infection in an HIV-positive man with previously confirmed immunity against hepatitis A virusYukihiro Yoshimura, Hiroshi Horiuchi, Nobuyuki Miyata, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 10, 2021
Recovery from severe persistent COVID-19 without evidence of an anti-SARS-CoV-2 antibody response in a man with mantle cell lymphoma treated with rituximabHiroshi Horiuchi, Hiroaki Sasaki, Kazuhito Miyazaki, et al.
The American Journal of Tropical Medicine and Hygiene|August 26, 2015
Cavity Forming Pneumonia Due to Staphylococcus aureus Following Dengue FeverNobuyuki Miyata, Yukihiro Yoshimura, Natsuo Tachikawa, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 27, 2016
Diseases affecting patients returning from abroad: Experience of a travel clinic in Japan from 2004 to 2014Yukihiro Yoshimura, Nobuyuki Miyata, Makiko Miyajima, et al.
Pageof 3